Search Results - "Palamidas, P"

Irinotecan plus gemcitabine vs irinotecan for the second-line treatment of patients with advanced non-small-cell lung cancer pretreated with docetaxel and cisplatin: a multicentre, randomised, phase II study by GEORGOULIAS, V, KOUROUSSIS, C, ARDAVANIS, A, TSELEPATIOTIS, E, VLACHONIKOLIS, I, AGELIDOU, A, BOUKOVINAS, I, PALAMIDAS, P, STAVRINIDIS, E, POLYZOS, A, SYRIGOS, K, VESLEMES, M, TOUBIS, M

“…To compare irinotecan (CPT-11)+gemcitabine vs CPT-11 alone as second-line treatment for patients with advanced non-small cell lung cancer (NSCLC) progressing…”
Get full text

The role of transbronchial needle aspiration in the diagnosis of peripheral lung masses or nodules by Katis, K, Inglesos, E, Zachariadis, E, Palamidas, P, Paraskevopoulos, I, Sideris, G, Tamvakopoulou, E, Apostolopoulou, F, Rasidakis, A

“…The purpose of this study was to evaluate the role of transbronchial needle aspiration (TBNA) in the diagnosis of peripheral lung lesions. We attempted to…”
Get full text

Platinum-based and non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a randomised multicentre trial by Georgoulias, V, Papadakis, E, Alexopoulos, A, Tsiafaki, X, Rapti, A, Veslemes, M, Palamidas, Ph, Vlachonikolis, I

“…Docetaxel in combination with cisplatin or gemcitabine are active chemotherapy reigimes against non-small-cell lung cancer. We compared the efficacy and safety…”
Get full text

Randomized comparison of etoposide-cisplatin vs. etoposide-carboplatin and irradiation in small-cell lung cancer. A Hellenic Co-operative Oncology Group study by Skarlos, D V, Samantas, E, Kosmidis, P, Fountzilas, G, Angelidou, M, Palamidas, P, Mylonakis, N, Provata, A, Papadakis, E, Klouvas, G

“…To compare the efficacy and toxicity of etoposide and cisplatin (EP) with etoposide and carboplatin (EC) in combination with irradiation in small-cell lung…”
Get more information

Comparison of docetaxel/cisplatin to docetaxel/gemcitabine as first-line treatment of advanced non-small cell lung cancer: early results of a randomized trial by Georgoulias, V., Samonis, G., Papadakis, E., Alexopoulos, A., Tsiafaki, X., Rapti, A., Veslemes, M., Grigoratou, Th, Palamidas, Ph, Kouroussis, Ch, Mavroudis, D., Kakolyris, S., Giannakakis, Th, Vlachonikolis, J.

“…The study compares docetaxel plus cisplatin (DC) and docetaxel plus gemcitabine (DG) regimens for the treatment of advanced non-small cell lung cancer (NSCLC)…”
Get full text

A dose escalation study of topotecan in combination with epirubicin in pretreated patients with small-cell lung cancer by Agelaki, S., Kakolyris, S., Palamidas, Ph, Kouroussis, Ch, Mavroudis, D., Kalbakis, K., Georgoulias, V., Raptis, A.

“…Purpose: To define the dose-limiting toxicities (DLTs) and the maximum tolerated doses (MTDs) of topotecan in combination with epirubicin in pretreated…”
Get full text

COGNET-MD, an evaluation framework and dataset for Large Language Model benchmarks in the medical domain by Panagoulias, Dimitrios P, Papatheodosiou, Persephone, Palamidas, Anastasios P, Sanoudos, Mattheos, Tsoureli-Nikita, Evridiki, Virvou, Maria, Tsihrintzis, George A

“…Large Language Models (LLMs) constitute a breakthrough state-of-the-art Artificial Intelligence (AI) technology which is rapidly evolving and promises to aid…”
Get full text